Hydroxychloroquine with thyroid hormone for recurrent pregnancy loss
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a combination of hydroxychloroquine (an anti-inflammatory drug) and levothyroxine (thyroid hormone) can improve live birth rates in women with recurrent pregnancy loss, normal thyroid function, and TPO antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 20 and 40 years old.
- You have had at least two pregnancy losses (including biochemical pregnancy) with the same partner.
- You and your partner have normal chromosome tests (no genetic abnormalities).
- You have a positive TPO antibody test (a thyroid antibody) but your thyroid hormone levels are normal.
- You do not have other autoimmune diseases, diabetes, high blood pressure, cancer, or severe kidney/liver problems.
- You are not currently taking steroids or immunosuppressant drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how couples are supported when they have had two or more pregnancy losses. It may help doctors understand what care works best for improving chances and support in a new pregnancy.
This trial tests whether a medicine called prednisolone can help prevent further miscarriages in people who have had recurrent miscarriages with no known cause. If you qualify, you would take prednisolone early in pregnancy and the study team would watch whether more losses occur.
This study explores a new supportive care program for people who have had multiple pregnancy losses and are pregnant again. It aims to see if extra attention and care can help reduce the risk of another loss.
This trial tests whether taking prednisolone, a steroid medicine, can improve immune cell activity in the uterus in women who have had 3 or more miscarriages. If it works, it could help reduce the chance of future pregnancy loss.
This trial tests if levothyroxine, a thyroid hormone medication, can help women with low thyroid hormone levels and a history of repeated miscarriages have a successful pregnancy. The study focuses on women who are currently pregnant before 20 weeks.
This study tests whether the thyroid medication levothyroxine can help women with a mildly high TSH level (between 2.5 and the upper limit of normal) during early pregnancy. It is for women who do not have thyroid antibodies and are otherwise healthy, to see if treatment improves pregnancy outcomes.
Hear when a new Recurrent Pregnancy Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.